Host Cell Actin Remodeling in Response to Cryptosporidium

  • Steven P. O’Hara
  • Aaron J. Small
  • Xian-Ming Chen
  • Nicholas F. LaRusso
Part of the Subcellular Biochemistry book series (SCBI, volume 47)


Despite sporadic reports of Cryptosporidium infection throughout the 1900s, the clinical significance of this parasite in humans was not recognized until the first documented human diagnosis of C. parvum in 1976,1,2 and the subsequent realization that as an opportunistic infectious agent, Cryptosporidium infection in AIDS patients was associated with significant morbidity and mortality3,4 and a causative agent of AIDS-related biliary disease.5 With the advent of highly active antiretroviral therapy, AIDS-related cryptosporidial disease occurs less frequently, yet Cryptosporidium is now recognized as a widely dispersed parasite and a significant enteropathogen of immunocompetent and immunocompromised hosts. Two species, C. hominis and C. parvum, readily infect humans. While C. parvum infects a wide range of mammalian hosts, C. hominis is believed to infect only humans. Most of the experimental evidence of host cell actin remodeling to date has been accomplished using C. parvum.


Actin Polymerization Cryptosporidium Parvum Membrane Protrusion Actin Reorganization Cryptosporidium Infection 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Meisel JL, Perera DR, Meligro C et al. Overwhelming watery diarrhea associated with Cryptosporidium in an immunosuppressed patient. Gastroenterology 1976; 70:1156–1160.PubMedGoogle Scholar
  2. 2.
    Nime FA, Burek DL, Page M et al. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 1976; 70:592–598.PubMedGoogle Scholar
  3. 3.
    Current WL, Reese NC, Ernst JV et al. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. New England Journal of Medicine 1983; 308:1252–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Soave R, Danner RL, Honig CL et al. Cryptosporidiosis in homosexual men. Annals of Internal Medicine 1984; 100:504–11.PubMedGoogle Scholar
  5. 5.
    Cockerill FR, Hurley DV, Malagelada JR et al. Polymicrobial cholangitis and Kaposi’s sarcoma in blood product transfusion-related acquired immune deficiency syndrome. American Journal of Medicine 1986; 80:1237–1241.PubMedCrossRefGoogle Scholar
  6. 6.
    Cello JP. Human immunodeficiency virus-associated biliary tract disease. Seminars in Liver Disease 1992; 12:213–218.PubMedCrossRefGoogle Scholar
  7. 7.
    Lopez-Velez R, Terazona R, Camacho AG et al. Intestinal and extraintestinal cryptosporidiosis in AIDS patients. European Journal of Clinical Microbiology and Infectious Diseases 1995; 14:677–681.CrossRefGoogle Scholar
  8. 8.
    Marcial MA, Madara JL. Cryptosporidium—Cellular-localization, structural-analysis of absorptive cell-parasite membrane-membrane interactions in guinea-pigs, and suggestion of protozoan transport by m-cells. Gastroenterology 1986; 90:583–594.PubMedGoogle Scholar
  9. 9.
    Lumb R, Smith K, Odonoghue PJ et al. Ultrastructure of the attachment of cryptosporidium sporozoites to tissue-culture cells. Parasitology Research 1988; 74:531–536.PubMedCrossRefGoogle Scholar
  10. 10.
    Aji T, Flanigan T, Marshall R et al. Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line. Journal of Protozoology 1991; 38:82s–84s.PubMedGoogle Scholar
  11. 11.
    Huang BQ, Chen XM, LaRusso NF. Mechanisms of attachment and internalization of Cryptosporidium parvum by biliary epithelia: A morphological study. Journal of Parasitology 2004; 90:212–221.PubMedCrossRefGoogle Scholar
  12. 12.
    Current WL, Reese NC. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. Journal of Protozoology 1986; 33:98–108.PubMedGoogle Scholar
  13. 13.
    Tzipori S, Griffiths JK. Natural history and biology of Cryptosporidium parvum. Advances in Parasitology—Opportunistic Protozoa in Humans. 1998:40:5–36.CrossRefGoogle Scholar
  14. 14.
    Bonnin A, Lapillonne A, Petrella T et al. Immunodetection of the microvillous cytoskeleton molecules villin and ezrin in the parasitophorous vacuole wall of Cryptosporidium parvum (Protozoa: Apicomplexa). European Journal of Cell Biology 1999; 78:794–801.PubMedGoogle Scholar
  15. 15.
    Elliott DA, Clark DP. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infection and Immunity 2000; 68:2315–2322.PubMedCrossRefGoogle Scholar
  16. 16.
    Forney JR, DeWald DB, Yang SG et al. A role for host phosphoinositide 3-kinase and cytoskeletal remodeling during Cryptosporidium parvum infection. Infection and Immunity 1999; 67:844–852.PubMedGoogle Scholar
  17. 17.
    Chen XM, LaRusso NF. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology 2000; 118:368–379.PubMedCrossRefGoogle Scholar
  18. 18.
    Elliott DA, Coleman DJ, Lane MA et al. Cryptosporidium parvum infection requires host cell actin polymerization. Infection and Immunity 2001; 69:5940–5942.PubMedCrossRefGoogle Scholar
  19. 19.
    Chen XM, Huang BQ, Splinter PL et al. Cdc42 and the actin-related protein/Neural Wiskott-Aldrich Syndrome Protein network mediate cellular invasion by Cryptosporidium parvum. Infection and Immunity 2004; 72:3011–3021.PubMedCrossRefGoogle Scholar
  20. 20.
    Chen XM, Huang BQ, Splinter PL et al. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. Gastroenterology 2003; 125:216–228.PubMedCrossRefGoogle Scholar
  21. 21.
    Chen XM, Splinter PL, Tietz PS et al. Phosphotidylinositol 3-kinase and Frabin mediate Cryptosporidium parvum cellular invasion via activation of Cdc42. The Journal of Biological Chemistry 2004; 279:31671–31678.PubMedCrossRefGoogle Scholar
  22. 22.
    Morisaki JH, Heuser JE, Sibley LD. Invasion of toxoplasma-gondii occurs by active penetration of the host-cell. Journal of Cell Science 1995; 108:2457–2464.PubMedGoogle Scholar
  23. 23.
    Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996; 84:933–939.PubMedCrossRefGoogle Scholar
  24. 24.
    Field SJ, Pinder JC, Clough B et al. Actin in the merozoite of the malaria parasite, Plasmodium falciparum. Cell Motility and the Cytoskeleton 1993; 25:43–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Gut J, Nelson RG. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. Journal of Eukaryotic Microbiology 1994; 41:42S–43S.PubMedGoogle Scholar
  26. 26.
    Forney JR, Vaughan DK, Yang S et al. Actin-dependent motility in Cryptosporidium parvum sporozoites. Journal of Parasitology 1998; 84:908–13.PubMedCrossRefGoogle Scholar
  27. 27.
    Arrowood MJ, Sterling CR, Healey MC. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. Journal of Parasitology 1991; 77:315–7.PubMedGoogle Scholar
  28. 28.
    Wetzel DW, Schmidt J, Kuhlenschmidt MS et al. Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites. Infection and Immunity 2005; 73:5379–5387.PubMedCrossRefGoogle Scholar
  29. 29.
    Agre P, King LS, Yasui M et al. Aquaporin water channels—from atomic structure to clinical medicine. Journal of Physiology (London) 2002; 542:3–16.PubMedCrossRefGoogle Scholar
  30. 30.
    Chen XM, O’Hara SP, Huang BQ et al. Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion. Proceedings from the National Academy of Sciences USA 2005; 102:6338–6343.CrossRefGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2008

Authors and Affiliations

  • Steven P. O’Hara
    • 1
  • Aaron J. Small
    • 1
  • Xian-Ming Chen
    • 1
  • Nicholas F. LaRusso
    • 1
  1. 1.Miles and Shirley Fiterman Center for Digestive DiseasesMayo ClinicRochesterUSA

Personalised recommendations